Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Tandem Diabetes Care (TNDM) over the last 13 years, with Q3 2025 value amounting to $1.3 million.

  • Tandem Diabetes Care's Change in Receivables fell 8892.34% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.9 million, marking a year-over-year increase of 8788.7%. This contributed to the annual value of $20.8 million for FY2024, which is 58620.53% up from last year.
  • Latest data reveals that Tandem Diabetes Care reported Change in Receivables of $1.3 million as of Q3 2025, which was down 8892.34% from $2.7 million recorded in Q2 2025.
  • Over the past 5 years, Tandem Diabetes Care's Change in Receivables peaked at $24.2 million during Q4 2021, and registered a low of -$22.8 million during Q1 2023.
  • Moreover, its 5-year median value for Change in Receivables was $6.9 million (2024), whereas its average is $3.7 million.
  • As far as peak fluctuations go, Tandem Diabetes Care's Change in Receivables tumbled by 20116.98% in 2021, and later surged by 21442.54% in 2024.
  • Quarter analysis of 5 years shows Tandem Diabetes Care's Change in Receivables stood at $24.2 million in 2021, then plummeted by 87.47% to $3.0 million in 2022, then skyrocketed by 84.41% to $5.6 million in 2023, then surged by 115.96% to $12.1 million in 2024, then tumbled by 89.39% to $1.3 million in 2025.
  • Its Change in Receivables stands at $1.3 million for Q3 2025, versus $2.7 million for Q2 2025 and $10.8 million for Q1 2025.